Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roberta Visconti
The Rationale for Druggability of CCDC6-tyrosine Kinase Fusions in Lung Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Retraction for Trapasso Et Al., “Rat Protein Tyrosine Phosphatase Η Suppresses the Neoplastic Phenotype of Retrovirally Transformed Thyroid Cells Through the Stabilization of P27Kip1”
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Related publications
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
Elucidating the Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer Patients
Canadian Journal of Biotechnology
Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer
Experimental & Molecular Medicine
Receptor Tyrosine Kinase Expression of Circulating Tumor Cells in Small Cell Lung Cancer
Oncoscience
Cancer Research
Oncology
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
Journal of Cancer
Oncology
Development of Crizotinib, a Rationally Designed Tyrosine Kinase Inhibitor for Non-Small Cell Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
